We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£520.00
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States
Price data last checked 82 day(s) ago - refreshing...
Price History & Forecast
Last 9 days • 9 data points (No recent data available)
Price Distribution
Price distribution over 9 days • 1 price levels
Price Analysis
Most common price: £520 (9 days, 100.0%)
Price range: £520 - £520
Price levels: 1 different prices over 9 days
Product Specifications
- Format
- paperback
- ASIN
- B0BLR59YBF
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 26 October 2022
- Listed Since
- 09 November 2022
Similar Products You Might Like
97% match
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics for US Zip Codes
£490.00
10 Dec 2025
97% match
The 2023-2028 Outlook for Sarcopenia Treatments in the United States
£520.00
05 Feb 2026
97% match
The 2023-2028 Outlook for Diabetic Gastroparesis Treatments in the United States
£520.00
07 Feb 2026
97% match
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States
£520.00
05 Feb 2026
97% match
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States
£520.00
14 Jan 2026
97% match
The 2023-2028 Outlook for Pen Insulin Syringes in the United States
£520.00
27 Jan 2026
97% match
The 2023-2028 Outlook for Diabetes Treatments in the United States
£520.00
10 Dec 2025
97% match
The 2023-2028 Outlook for Erythropoietin Drugs in the United States
£520.00
06 Feb 2026
97% match
The 2023-2028 Outlook for Diabetes Drugs in the United States
£520.00
10 Dec 2025
97% match
The 2023-2028 Outlook for Diabetic Foot Ulcer Therapeutics in the United States
£520.00
12 Jan 2026
97% match
The 2023-2028 Outlook for Insulin Pen Needles in the United States
£520.00
24 Jan 2026
97% match
The 2023-2028 Outlook for Enteric Disease Testing-Treatment in the United States
£520.00
27 Jan 2026
97% match
The 2023-2028 Outlook for Insomnia Therapeutics in the United States
£520.00
15 Jan 2026
96% match
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in the United States
£520.00
07 Feb 2026
96% match
The 2023-2028 Outlook for Non-Opioid Pain Treatments in the United States
£520.00
30 Jan 2026
96% match
The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in the United States
£520.00
07 Feb 2026
96% match
The 2023-2028 Outlook for Insulin Delivery Systems in the United States
£520.00
25 Jan 2026
96% match
The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in the United States
£520.00
28 Jan 2026
96% match
The 2023-2028 Outlook for Pruritus Corticosteroid Therapeutics in the United States
£520.00
30 Jan 2026
96% match
The 2023-2028 Outlook for Diabetic Nephropathy Treatments in the United States
£520.00
24 Jan 2026
96% match
The 2023-2028 Outlook for Diabetes Care Products in the United States
£520.00
28 Jan 2026
96% match
The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in the United States
£520.00
29 Jan 2026
96% match
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in the United States
£520.00
05 Feb 2026
96% match
The 2023-2028 Outlook for Peripheral Neuropathy Treatments in the United States
£520.00
21 Apr 2026